Condition: Liver Failure · Sponsor: Ningbo Medical Center Lihuili Hospital
To investigate the safety, adverse reactions and therapeutic effects of fecal microbiota transplantation on patients with liver failure;to investigate the effect of fecal microbiota transplantation on the intestinal microecology and "gut-liver axis immune system" of liver failure, and further optimization of fecal microbiota transplantation technology.
This description comes directly from the study's public registry record.
lanman Xu · +86 13587646315 · 13587646315@163.com
Always discuss trial participation with your own doctor first.
| Ningbo Medical Center Lihuili Hospital,Affiliated Lihuili hospital of Ningbo University | Ningbo, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05170971